Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sebum Sampling and Metabolomics/Lipidomics Analysis Protocol Development
NCT07549828Not yet recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2026
- Primary completion
- Mar 2029
01
Overview
Open-label, single-arm trial, sponsored by National Taiwan University Hospital. Primary endpoints: Concentration of Sebum Lipids Measured by LC-MS/MS at 3 months and Relative Abundance of Skin Microbiome Composition Assessed by Sequencing at 3 months. Planned start Apr 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07549828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549828.